The optimal length of ‘coasting protocol’ in women at risk of ovarian hyperstimulation syndrome undergoing in vitro fertilization

References

• Abramov Y., Fatum M., Abrahamov D., Schenker J. G. Hydroxyethyl starch versus human albumin for the treatment of severe ovarian hyperstimulation syndrome: A preliminary report. Fertility and Sterility 2001; 75: 1228–1230
   PubMedGoogle Scholar
• Agrawal R., Tan S. L., Wild S., Sladkevicius P., Engmann L., Payne N., et al. Serum vascular endothelial growth factor concentrations in in vitro fertilization cycles predict the risk of ovarian hyperstimulation syndrome. Fertility and Sterility 1999; 71: 287–293
   PubMed Web of Science ®Google Scholar
• Al-Shawaf T., Zosmer A., Hussain S., Tozer A., Panay N., Wilson, et al. Prevention of severe ovarian hyperstimulation syndrome in IVF with or without ICSI and embryo transfer: A modified ‘coasting’ strategy based on ultrasound for identification of high-risk patients. Human Reproduction 2001; 16: 24–30
   PubMed Web of Science ®Google Scholar
• Amso N. N., Ahuja K. K., Morris N., Shaw R. W. The management of predicted ovarian hyperstimulation involving gonadotrophin-releasing hormone analogue with elective cryopreservation of all pre-embryos. Fertility and Sterility 1990; 53: 1087–1090
   PubMed Web of Science ®Google Scholar
• Asch R. H., Ivery G., Goldsman M., Frederick J. L., Stone S. C., Balmaceda J. P. The use of intravenous albumin in patients at high risk for severe ovarian hyperstimulation syndrome. Human Reproduction 1993; 8: 1015–1020
   PubMed Web of Science ®Google Scholar
• Beerendonk C. C. M., van Dop P. A., Braat D. D. M., Merkus J. M. W. M. Ovarian hyperstimulation syndrome: facts and fallacies. Obstetrical and Gynecological Survey 1998; 53: 439–449
   PubMedGoogle Scholar
• Chen D., Burmeister L., Goldschlag D., Rosenwaks Z. Ovarian hyperstimulation syndrome: Strategies for prevention. Reproductive Biomedicine Online 2003; 6: 43–49
   Google Scholar
• Child T. J., Abdul-Jalil A. K., Gulekli B., Tan S. L. In vitro maturation and fertilization of oocytes from unstimulated normal ovaries, polycystic ovaries, and women with polycystic ovary syndrome. Fertility and Sterility 2001; 76: 936–942
   PubMed Web of Science ®Google Scholar
• D'Angelo A., Amso N. Coasting (withholding gonadotrophins) for preventing ovarian hyperstimulation syndrome. Cochrane Database of Systematic Reviews 2002; 3, CD 002811
   Google Scholar
• Delvigne A., Rozenberg S. Preventive attitude of physicians to avoid OHSS in IVF patients. Human Reproduction 2001; 16: 2491–2495
   PubMed Web of Science ®Google Scholar
• Egbase P. E., Al Sharhan M., Grudzinskas J. G. Early unilateral follicular aspiration compared with coasting for the prevention of severe ovarian hyperstimulation syndrome: A prospective randomized study. Human Reproduction 1999; 14: 1421–1425
   PubMed Web of Science ®Google Scholar
• European Recombinant LH Study Group. Recombinant human luteinizing hormone is as effective as, but safer than, urinary human chorionic gonadotropin in inducing final follicular maturation and ovulation in in-vitro fertilization procedures: Results of a multicenter double-blind study. Journal of Clinical Endocrinology and Metabolism 2001; 86: 2607–2618
   PubMed Web of Science ®Google Scholar
• Fluker M. R., Hooper W. M., Yuzpe A. A. Withholding gonadotrophins (‘coasting’) to minimize the risk of ovarian hyperstimulation during superovulation and in vitro fertilization-embryo transfer cycles. Fertility and Sterility 1999; 71: 294–231
   PubMed Web of Science ®Google Scholar
• Forman R. G., Frydman R., Egan D., Ross C., Barlow D. H. Severe ovarian hyperstimulation syndrome using agonists of gonadotropin-releasing hormone for in vitro fertilization: A European series and a proposal for prevention. Fertility and Sterility 1990; 53: 502–509
   PubMed Web of Science ®Google Scholar
• García-Velasco J. A., Zúñiga A., Pacheco A., Gomez R., Simon C., Remohi J., Pellicer A. Coasting acts through downregulation of VEGF gene expression and protein secretion. Human Reproduction 2004; 19: 1530–1538
   PubMedGoogle Scholar
• Gomez R., Simon C., Remohi J., Pellicer A. Administration of moderate and high doses of gonadotrophins to female rats increases ovarian vascular endothelial growth factor (VEGF) and VEGF receptor-2 expression that is associated to vascular hyperpermeablity. Biology of Reproduction 2003; 68: 2164–2171
   PubMed Web of Science ®Google Scholar
• Isaza V., García-Velasco J. A., Aragonés M., Remohí J., Simón C., Pellicer A. Oocyte and embryo quality after coasting: the experience from oocyte donation. Human Reproduction 2002; 17: 1777–1782
   PubMed Web of Science ®Google Scholar
• Levinsohn-Tavor O., Friedler S., Shachter M., Raziel A., Strassburger D., Ron-El R. Coasting – what is the best formula?. Human Reproduction 2003; 18: 937–940
   PubMedGoogle Scholar
• Mansour R., Aboulghar M., Serour G., Amin Y., Abou-Setta A. M. Criteria of a successful coasting protocol for the prevention of severe ovarian hyperstimulation syndrome. Human Reproduction 2005; 20: 3167–3172
   PubMed Web of Science ®Google Scholar
• McClure N., Healy D. L., Rogers P. A., Sullivan J., Beaton L., Haning R. V., Jr., et al. Vascular endothelial growth factor as capillary permeability agent in ovarian hyperstimulation syndrome. Lancet 1994; 344: 235–236
   PubMed Web of Science ®Google Scholar
• Moreno L., Diaz I., Pacheco A., Zúñiga A., Requena A., García-Velasco J. A. Extended coasting duration exerts a negative impact on IVF cycle outcome due to premature luteinization. Reproductive BioMedicine Online 2004; 9: 500–504
   Google Scholar
• Navot D., Bergh P. A., Laufer N. Ovarian hyperstimulation syndrome in novel reproductive technologies: Prevention and treatment. Fertility and Sterility 1992; 58: 249–261
   PubMed Web of Science ®Google Scholar
• Rizk B., Smitz J. Ovarian hyperstimulation syndrome after superovulation using GnRH agonists for IVF and related procedures. Human Reproduction 1992; 7: 320–327
   PubMedGoogle Scholar
• Shalev E., Geslevich Y., Ben-Ami M. Induction of pre-ovulatory luteinizing hormone surge by gonadotrophin-releasing hormone agonist for women at risk for developing the ovarian hyperstimulation syndrome. Human Reproduction 1994; 9: 417–419
   PubMedGoogle Scholar
• Sher G., Salem R., Feinman M., Dodge S., Zouves C., Knutzen V. Eliminating the risk of life-endangering complications following overstimulation with menotropin fertility agents: a report on women undergoing in vitro fertilization and embryo transfer. Obstetrics and Gynecology 1993; 81: 1009–1011
   PubMed Web of Science ®Google Scholar
• Sher G., Zouves C., Feinman M., Maassarani G. ‘Prolonged coasting’: An effective method for preventing severe ovarian hyperstimulation syndrome in patients undergoing in-vitro fertilization. Human Reproduction 1995; 10: 3107–3109
   PubMedGoogle Scholar
• Simón C., Cano F., Valbuena D., Remohi J., Pellicer A. Clinical evidence for a detrimental effect on uterine receptivity of high serum oestradiol concentrations in high and normal responder patients. Human Reproduction 1995; 10: 2432–2437
   PubMed Web of Science ®Google Scholar
• Smitz J., Camus M., Devroey P., Erard P., Wisanto A., Van Steirteghem A. C. Incidence of severe ovarian hyperstimulation syndrome after GnRH agonist/HMG superovulation for in-vitro fertilization. Human Reproduction 1990; 5: 933–937
   Google Scholar
• Tomazevic T., Meden-Vrtovec H. Early timed follicular aspiration prevents severe ovarian hyperstimulation syndrome. Journal of Assisted Reproduction and Genetics 1996; 13: 282–286
   PubMed Web of Science ®Google Scholar
• Tortoriello D. V., McGovern P. G., Colon J. M., Loughlin J., Santoro N. ‘Coasting’ does not adversely affect cycle outcome in a subset of highly responsive in vitro fertilization patients. Fertility and Sterility 1998; 69: 454–460
   PubMed Web of Science ®Google Scholar
• Ulug U., Bahceci M., Erden H. F., Shalev E., Ben-Shlomo I. The significance of coasting duration during ovarian stimulation for conception in assisted fertilization cycles. Human Reproduction 2002; 17: 310–313
   PubMedGoogle Scholar
• Ulug U., Ben-Shlomo I., Bahceci M. Predictors of success during the coasting period in high-responder patients undergoing controlled ovarian stimulation for assisted conception. Fertility and Sterility 2004; 82: 338–342
   PubMedGoogle Scholar
• Wada I., Matson P. L., Horne G., Buck P., Lieberman B. A. Is continuation of a gonadotrophin-releasing hormone agonist (GnRHa) necessary for women at risk of developing the ovarian hyperstimulation syndrome?. Human Reproduction 1992; 7: 1090–1093
   PubMedGoogle Scholar
• Waldenstrom U., Kahn J., Marsk L., Nilsson S. High pregnancy rates and successful prevention of severe ovarian hyperstimulation syndrome by ‘prolonged coasting’ of very hyperstimulated patients: a multicentre study. Human Reproduction 1999; 14: 294–297
   PubMedGoogle Scholar
• Whelan III J. G., Vlahos N. F. The ovarian hyperstimulation syndrome. Fertility and Sterility 2000; 73: 883–896
   Google Scholar